ProCE Banner Activity

My Thoughts on the Current and Emerging Treatment of CLL/SLL

Clinical Thought

Read my take on the current treatment of patients with CLL/SLL, ongoing clinical challenges, and emerging strategies to watch.  

Released: October 25, 2024

Expiration: October 24, 2025

Share

Faculty

Alessandra Tedeschi

Alessandra Tedeschi, MD

Consultant in Hematology
Division of Hematology
Niguarda Hospital
Milano, Italy

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca

Disclosure

Primary Author

Alessandra Tedeschi, MD

Consultant in Hematology
Division of Hematology
Niguarda Hospital
Milano, Italy

Alessandra Tedeschi, MD: consultant/advisor/speaker: AbbVie, AstraZeneca, BeiGene, Johnson & Johnson, Lilly.